A study of the in vitro interaction between ethanol, and triazolam and its two metabolites using human liver microsomes.

[1]  M. Goldman,et al.  Quick Look Drug Book , 2010 .

[2]  E. Tanaka.  Toxicological Interactions Between Alcohol and Benzodiazepines , 2002, Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology.

[3]  C. L. Winek,et al.  Drug and chemical blood-level data 2001. , 2001, Forensic science international.

[4]  P. Neuvonen,et al.  Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life , 2000, European Journal of Clinical Pharmacology.

[5]  D. Greenblatt,et al.  Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole , 2000, European Journal of Clinical Pharmacology.

[6]  D. Greenblatt,et al.  Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. , 2000, The Journal of pharmacology and experimental therapeutics.

[7]  H. Boxenbaum.  Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general. , 1999, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[8]  W. Busby,et al.  Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[9]  E. Tanaka,et al.  Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants – an update , 1998, Journal of clinical pharmacy and therapeutics.

[10]  D. Greenblatt,et al.  Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences , 1998, Clinical pharmacology and therapeutics.

[11]  K. Kitson,et al.  Ethanol and acetaldehyde metabolism: past, present, and future. , 1996, Alcoholism, clinical and experimental research.

[12]  A. Cederbaum,et al.  Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. , 1996, Alcoholism, clinical and experimental research.

[13]  J S Harmatz,et al.  Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. , 1996, The Journal of pharmacology and experimental therapeutics.

[14]  S. Imaoka,et al.  Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. , 1995, The Journal of pharmacology and experimental therapeutics.

[15]  S. Komura,et al.  Death Caused by Triazolam and Ethanol Intoxication , 1995, The American journal of forensic medicine and pathology.

[16]  B. Joynt.  Triazolam blood concentrations in forensic cases in Canada. , 1993, Journal of Analytical Toxicology.

[17]  J. O'Dowd,et al.  Fatal triazolam poisoning. , 1988, BMJ.

[18]  D. Greenblatt,et al.  Triazolam and ethanol interaction: Kinetic and dynamic consequences , 1985, Clinical pharmacology and therapeutics.

[19]  D. Greenblatt,et al.  Pharmacokinetic noninteraction of triazolam and ethanol. , 1984, Journal of clinical psychopharmacology.

[20]  C. Lieber.  Mechanisms of ethanol-drug-nutrition interactions. , 1994, Journal of toxicology. Clinical toxicology.

[21]  Lieber Cs.  Susceptibility to alcohol-related liver injury. , 1994 .

[22]  K. Worm,et al.  Cases of fatal triazolam poisoning. , 1993, Journal - Forensic Science Society.